// App-Quantinova.ai

: Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia – The BESTCILIA randomized placebo-controlled trial

Researchers

Presenter

  • Helene Kobbernagel

Principal Investigators

  • Frederik F. Buchvald

  • Eric G. Haarman

  • Carmen Casaulta

  • Samuel A. Collins

  • Claire Hogg

  • Claudia E. Kuehni

  • Jane S. Lucas

  • Heymut Omran

  • Alexandra L. Quittner

  • Claudius Werner

  • Susanne Rosthj

  • Anne L. Srensen

  • Kim G. Nielsen

Medical Centers

  • Danish PCD Centre, Pediatric Pulmonary Service, Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Division of Respiratory Medicine, Department of Pediatrics, Inselspital and University of Bern, Bern, Switzerland

  • Primary Ciliary Dyskinesia Centre, NIHR Biomedical Research Centre, University of Southampton, Southampton, United Kingdom

  • Paediatric Respiratory Department, Royal Brompton Hospital, London, United Kingdom

  • Institute of Social and Preventive Medicine, University of Bern, & Division of Respiratory Medicine, Department of Pediatrics, Inselspital, Bern, Switzerland

  • Department of General Pediatrics, University Childrens Hospital, Munster, Germany

  • Nicklaus Children’s Research Institute, Miami, Florida, United States of America

  • Department of Pediatrics, Helios Hospital Schwerin, Schwerin, Germany

  • Section of Biostatistics, Department of Public Health, University of Copenhagen

Locations

  • Denmark

  • Netherlands

  • Switzerland

  • United Kingdom

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

Disease

  • Primary ciliary dyskinesia

Biomarkers

  • N/A

Drug/Treatment

  • Azithromycin

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

  • Parallel Group

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A